Digital How biotech can leverage scientific enterprise SaaS By considering how to build a solid data foundation from the beginnings, smaller start-ups or biotechs can make sure they are ready to go.
Market Access Biotech ≠ tech: Why venture capital needs a new playbook for... Silicon Valley investors have been conditioned by two decades of software: launch quickly, capture users faster, and hit the magic $1 million ARR mark within about three years,1
Digital Pharma dips toe into tech adoption, but is it deep enough? Ben Hargreaves looks at the uptake of enabling technology by the pharma industry.
News FDA follows experts' advice and blocks Capricor DMD therapy The FDA has dashed Capricor's hope of getting approval for its cell therapy for Duchenne muscular dystrophy, wreaking havoc with its share price.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.